Financial News
Latest News about NARI
Recent news which mentions NARI
A Look at GoodRx, Inari, and Amwell
February 20, 2021
From Motley Fool
Have $3,000? Smart Investors Are Piling Into These 2 Stocks
February 17, 2021
From Motley Fool
The Daily Biotech Pulse: Novartis Funding For Gene Therapy Research, Priority Review For Amgen Cancer Drug, Pfizer-BioNTech Vaccine Supply Deal
February 17, 2021
From Benzinga
The Daily Biotech Pulse: DermTech Soars On Contract, Fluidigm Plunges On Earnings, Decision Day For Regeneron, Bioventus Debuts
February 11, 2021
From Benzinga
The Daily Biotech Pulse: Lilly COVID-19 Antibody Cocktail Approved for Emergency Use, Gamida, Genfit Jump On Data, 2 IPOs
February 10, 2021
From Benzinga
The Daily Biotech Pulse: Dynavax Poaches GSK Vaccine Exec, KalVista Jumps On Data Readout, Corcept Issues Negative Preannouncement
February 09, 2021
From Benzinga
The Daily Biotech Pulse: J&J Files For COVID-19 Vaccine Approval, Zimmer Biomet's Spin-Off, IPO Deluge Hits Street
February 05, 2021
From Benzinga
The Daily Biotech Pulse: Sorrento, Immutep Surge On COVID-19 Study Data, T2 Biosystems Sinks On Preannouncement
January 27, 2021
From Benzinga
The Daily Biotech Pulse: Novartis Misses, J&J Beats In Big Pharma Earnings, Vaccine Developer CureVac Taps Equity Market
January 26, 2021
From Benzinga
Stocks That Hit 52-Week Highs On Monday
January 25, 2021
From Benzinga
The Daily Biotech Pulse: Fluidigm's Saliva-Based COVID Test Approved In Europe, China Backs Amarin's Vascepa
January 22, 2021
From Benzinga
From Benzinga
The Daily Biotech Pulse: FDA Greenlights Merck's Heart Failure Drug, Histogen Hit With Clinical Hold, Aptorum Gets Nod For Commencing Human Study
January 20, 2021
From Benzinga
The Daily Biotech Pulse: Alexion Pauses COVID-19 Study, NantKwest Readout, Organogenesis Jumps On Guidance, Trial Updates
January 14, 2021
From Benzinga
Stocks That Hit 52-Week Highs On Thursday
December 31, 2020
From Benzinga
Stocks That Hit 52-Week Highs On Wednesday
December 30, 2020
From Benzinga
The Daily Biotech Pulse: Osmotica Faces Second FDA Rejection, UK Conditionally Approves AstraZeneca's Vaccine Candidate, Hepion NASH Data
December 30, 2020
From Benzinga
Stocks That Hit 52-Week Highs On Tuesday
December 29, 2020
From Benzinga
The Daily Biotech Pulse: FDA Nod For Amphastar's Generic Glucagon, Arcturus Sinks On Vaccine Data, Decision Day For Osmotica
December 29, 2020
From Benzinga
Stocks That Hit 52-Week Highs On Monday
December 28, 2020
From Benzinga
Benzinga's Top Upgrades, Downgrades For November 18, 2020
November 18, 2020
From Benzinga
10 Biggest Price Target Changes For Friday
November 13, 2020
From Benzinga
The Daily Biotech Pulse: AstraZeneca's Cancer Drug Flunks COVID-19 Studies, Five Prime On a Roll, Morphosys, Xencor, Incyte Strike Cancer Deal
November 12, 2020
From Benzinga
Earnings Scheduled For November 12, 2020
November 12, 2020
From Benzinga
The Week Ahead In Biotech: Supernus, Sanofi Await FDA Decisions
November 08, 2020
From Benzinga
The Daily Biotech Pulse: Sanofi, Regeneron Drop COVID-19 Study, 2 Positive AstraZeneca Catalysts, Brickell Awarded Japanese Patent
September 01, 2020
From Benzinga
Stocks That Hit 52-Week Highs On Friday
August 28, 2020
From Benzinga
The Daily Biotech Pulse: Moderna Japanese Vaccine Deal Talk, Lipocine FDA Decision, Liver Congress Presentations
August 28, 2020
From Benzinga
Stocks That Hit 52-Week Highs On Thursday
August 27, 2020
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
